These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9352708)

  • 21. Excision of residual masses of metastatic germ cell tumours after chemotherapy: the role of extraperitoneal surgical approaches.
    Christmas TJ; Doherty AP; Rustin GJ; Seckl MJ; Newlands ES
    Br J Urol; 1998 Feb; 81(2):301-8. PubMed ID: 9488076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes after resection of postchemotherapy residual neck mass in patients with germ cell tumors--an update.
    Gupta A; Feifer AH; Gotto GT; Kraus D; Motzer R; Bosl GJ; Bajorin D; Feldman DR; Carver B; Sheinfeld J
    Urology; 2011 Mar; 77(3):655-9. PubMed ID: 21377010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
    Djaladat H; Nichols C; Daneshmand S
    Ann Surg Oncol; 2012 Jul; 19(7):2388-93. PubMed ID: 22395993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeat retroperitoneal lymph node dissection for metastatic testis cancer.
    Sexton WJ; Wood CG; Kim R; Pisters LL
    J Urol; 2003 Apr; 169(4):1353-6. PubMed ID: 12629359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group.
    Steyerberg EW; Donohue JP; Gerl A; Toner GC; Schraffordt Koops H; Fosså SD; Keizer HJ
    J Urol; 1997 Aug; 158(2):474-8. PubMed ID: 9224327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratoma.
    Rabbani F; Farivar-Mohseni H; Leon A; Motzer RJ; Bosl GJ; Sheinfeld J
    Urology; 2003 Dec; 62(6):1092-6. PubMed ID: 14665362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer.
    Steyerberg EW; Gerl A; Fossá SD; Sleijfer DT; de Wit R; Kirkels WJ; Schmeller N; Clemm C; Habbema JD; Keizer HJ
    J Clin Oncol; 1998 Jan; 16(1):269-74. PubMed ID: 9440752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

  • 29. Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.
    Gerl A; Clemm C; Schmeller N; Dienemann H; Weiss M; Kriegmair M; Löhrs U; Wilmanns W
    Br J Cancer; 1994 Nov; 70(5):960-5. PubMed ID: 7524606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic supine robotic retroperitoneal lymph node dissection for post-chemotherapy residual masses in testicular cancer: technique and outcome analysis of initial experience.
    Tamhankar AS; Patil SR; Ojha SP; Ahluwalia P; Gautam G
    J Robot Surg; 2019 Dec; 13(6):747-756. PubMed ID: 30656537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retroperitoneal lymph node dissection after chemotherapy.
    Winter C; Raman JD; Sheinfeld J; Albers P
    BJU Int; 2009 Nov; 104(9 Pt B):1404-12. PubMed ID: 19840021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary vs. post-chemotherapy retroperitoneal lymph node dissection (RPLND) in patients with presence of teratoma at orchiectomy.
    Williams SB; Kacker R; Steele GS; Richie JP
    Urol Oncol; 2012; 30(1):60-3. PubMed ID: 20189842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal masses.
    Hendry WF; Norman AR; Dearnaley DP; Fisher C; Nicholls J; Huddart RA; Horwich A
    Cancer; 2002 Mar; 94(6):1668-76. PubMed ID: 11920527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer tumors of the testis.
    Culine S
    Eur Urol; 2008 Feb; 53(2):273-4. PubMed ID: 18045772
    [No Abstract]   [Full Text] [Related]  

  • 35. Improved prognosis of patients with intermediate- and poor-risk nonseminomatous germ cell tumours by optimizing combined treatment.
    Pentheroudakis G; De Bono JS; Kaye SB; Simpson A; Paul J; Brown I; Pamenter B; Kirk A; Vasey P; Raby N; Kirk D
    BJU Int; 2003 Jul; 92(1):36-42. PubMed ID: 12823380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Case of testicular cancer with malignant transformation in the residual retroperitoneal mature teratoma 8 years after the initial chemotherapy].
    Ito K; Iigaya T; Umezawa A
    Nihon Hinyokika Gakkai Zasshi; 1998 Jun; 89(6):622-6. PubMed ID: 9666691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical study of retroperitoneal lymph node dissection for patients with advanced germ cell tumors].
    Okamura K; Yuba H; Nishimura T; Mizutani K; Takashi M; Gotoh M; Ono Y; Ohshima S
    Hinyokika Kiyo; 1999 Feb; 45(2):95-101. PubMed ID: 10212781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group.
    Gerdtsson A; Thor A; Grenabo Bergdahl A; Almås B; Håkansson U; Törnblom M; Negaard HFS; Glimelius I; Halvorsen D; Karlsdóttir Á; Sagstuen Haugnes H; Engen Andreassen K; Melsen Larsen S; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Ståhl O; Kjellman A
    Eur Urol Oncol; 2022 Apr; 5(2):235-243. PubMed ID: 33750683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors of the testis.
    Jacqmin D
    Eur Urol; 2008 Feb; 53(2):272-3. PubMed ID: 18045771
    [No Abstract]   [Full Text] [Related]  

  • 40. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis.
    Heidenreich A; Thüer D; Polyakov S
    Eur Urol; 2008 Feb; 53(2):260-72. PubMed ID: 18045770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.